Diskussionsleitung: D. Linz (Maastricht, NL), M. Paul (Münster)
| (P1831) | Effect of Whole Thorax Irradiation on Cardiac Remodeling after Ischemia/Reperfusion Injury | |
| S. Mir, K. Wegener, S. Gorressen, S. Twarock, J. Haendeler, J. Altschmied, A. Sak, M. Stuschke, V. Jendrossek, J. W. Fischer, U. Flögel, M. Grandoch (Düsseldorf, Essen) | ||
| (P1832) | Safe electrophysiologic profile of sacubitril in combination with different antiarrhythmic drugs | |
| C. Ellermann, C. Mengel, J. Wolfes, K. Willy, F. K. Wegner, P. Niehues, F. Reinke, L. Eckardt, G. Frommeyer (Münster) | ||
| (P1833) | Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration | |
| L. Nicolai (München) | ||
| (P1834) | Hemoglobin A1c and long-term mortality in patients undergoing coronary angiography – the ECAD registry | |
| I. Dykun, S. Hendricks, O. Babinets, F. Al-Rashid, M. Totzeck, T. Rassaf, A.-A. Mahabadi (Essen) | ||
| (P1835) | Low-density lipoprotein-cholesterol reduction in very high-risk patients through lipid lowering therapy in lipid clinic | |
| D. Pinsdorf, M. Bahar, M. Steinmetz, O. Petrikhovich, A.-A. Mahabadi, C. Rammos, T. Rassaf, J. Lortz (Essen) | ||
| (P1836) | Dynamics of natriuretic peptides in response to physical exercise in chronic thromboembolic pulmonary hypertension (CTEPH) | |
| S. Kriechbaum, J. Birmes, C. Wiedenroth, M. Adameit, S. Guth, F. Roller, M. Rademann, U. Fischer-Rasokat, C. Liebetrau, C. W. Hamm, T. Keller, A. Rieth, für die Studiengruppen: BioReg, SFB-CRC1213 (Bad Nauheim, Gießen, Frankfurt am Main) | ||
| (P1837) | Sleep apnea and cardiovascular mortality in patients with heritable thoracic aortic diseases (HTAD) | |
| N. Geßler, P. Wohlmuth, O. Anwar, S. Debus, C. Eickholt, M. A. Gunawardene, S. Hakmi, K. Heitmann, M. Rybczynski, H. Schüler, S. Sheikhzadeh, E. P. Tigges, G. H. Wiest, S. Willems, E. Adam, Y. von Kodolitsch (Hamburg) |